Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Fungal Phylum Basidiomycota01:26

Fungal Phylum Basidiomycota

410
Basidiomycota is a diverse phylum of fungi that includes ecologically significant decomposers such as white rot fungi, symbionts like mycorrhizal fungi, plant pathogens such as rusts and smuts, and edible species like Agaricus bisporus (the common button mushroom). These fungi play crucial roles in nutrient cycling, symbiotic relationships, and even human health. Their defining feature is the basidium, a microscopic club-shaped structure responsible for producing basidiospores.Fruiting Bodies...
410
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

326
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
326
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

183
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
183
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

339
Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
339
Overview of Fungi01:29

Overview of Fungi

310
Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...
310

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology and Clinical Features of Cryptococcosis Among Individuals Without HIV Infection: An Observational International Multicenter Study (MSG-11).

Open forum infectious diseases·2026
Same author

Exploring Early Antifungal Activity of Rezafungin as a Stepping-Stone for Shorter Treatment Duration for Candidemia: Pooled Analysis of 2 Randomized Trials.

Open forum infectious diseases·2026
Same author

Development Framework of Desirability of Outcome Ranking Endpoints for Use in Clinical Trials of Invasive Fungal Diseases.

Open forum infectious diseases·2026
Same author

Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis: Results from the Double-blind, Randomized, Phase 3 ReSTORE Trial Including the China Extension Study.

Open forum infectious diseases·2025
Same author

Histopathologic Insights Into Curvularia-Induced Chronic Granulomatous Fungal Sinusitis: A Guide for Surgical Pathologists.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2025
Same author

COVID-19-associated Pulmonary Aspergillosis in Mechanically Ventilated Patients at 7 US Hospitals: Epidemiology and Estimated Likelihood of Invasive Pulmonary Aspergillosis-Results of the Prospective MSG-017 Study.

Open forum infectious diseases·2025
Same journal

Retraction: Commentary: One mechanism of Sishen Pill on diarrhea with kidney Yang deficiency syndrome: influencing metabolic function by intestinal microorganisms and enzyme activity mediates the gut-kidney axis.

Frontiers in cellular and infection microbiology·2026
Same journal

The CRISPR-Cas toolkit for mosquito-borne virus surveillance: detection, tracing, and discovery.

Frontiers in cellular and infection microbiology·2026
Same journal

Distinctive reproductive tract microbial characteristics associated with infertility in women: a systematic review and meta-analysis.

Frontiers in cellular and infection microbiology·2026
Same journal

STING agonist 2'3'-cGAMP as an effective adjuvant for HPV16 peptide vaccine enhances anti-tumor immunity in TC-1 mice models.

Frontiers in cellular and infection microbiology·2026
Same journal

Development and validation of a risk prediction model for hospital mortality in adult patients with <i>Staphylococcus aureus</i> bacteremia.

Frontiers in cellular and infection microbiology·2026
Same journal

Exploratory model-based optimizing isavuconazole dosing regimens for <i>Aspergillus</i> spp. in adult patients according to serum albumin levels: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.

Frontiers in cellular and infection microbiology·2026
See all related articles

Related Experiment Video

Updated: Oct 19, 2025

Candida albicans Biofilm Chip CaBChip for High-throughput Antifungal Drug Screening
08:05

Candida albicans Biofilm Chip CaBChip for High-throughput Antifungal Drug Screening

Published on: July 18, 2012

13.9K

Antifungal Pipeline.

Todd Patrick McCarty1,2, Peter G Pappas1

  • 1Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.

Frontiers in Cellular and Infection Microbiology
|September 23, 2021
PubMed
Summary
This summary is machine-generated.

New antifungal drugs are emerging to combat rising resistance and new fungal infections. This review highlights seven promising agents with novel mechanisms of action to aid physicians in treating challenging fungal diseases.

Keywords:
Candidaantifungalantimicrobialsaspergillosisfungal infectionsmycology

More Related Videos

Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

2.5K
Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

19.3K

Related Experiment Videos

Last Updated: Oct 19, 2025

Candida albicans Biofilm Chip CaBChip for High-throughput Antifungal Drug Screening
08:05

Candida albicans Biofilm Chip CaBChip for High-throughput Antifungal Drug Screening

Published on: July 18, 2012

13.9K
Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

2.5K
Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

19.3K

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Fungal infections are often neglected compared to bacterial infections, leading to less development in antifungal agents.
  • Recent approvals primarily feature variations of existing antifungal drug classes, not novel mechanisms.
  • Rising antifungal resistance and emerging fungal pathogens necessitate new treatment strategies.

Purpose of the Study:

  • To review promising antifungal agents in advanced development.
  • To highlight novel mechanisms of action and dosing regimens.
  • To provide physicians with options for treating mucocutaneous and invasive fungal infections.

Main Methods:

  • Review of antifungal agents in late-stage clinical development.
  • Analysis of novel mechanisms of action and dosing strategies.
  • Focus on agents targeting resistant and emerging fungal pathogens.

Main Results:

  • Identification of seven antifungal agents nearing market availability.
  • These agents offer new mechanisms of action to overcome resistance.
  • Novel dosing regimens are also presented for improved patient management.

Conclusions:

  • The pipeline for new antifungal therapies is strengthening.
  • These upcoming agents promise to address the critical need for novel treatments in clinical mycology.
  • Physicians will soon have expanded options to combat difficult fungal infections.